478 related articles for article (PubMed ID: 21669033)
1. Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line.
Cheng M; Ma J; Chen Y; Zhang J; Zhao W; Zhang J; Wei H; Ling B; Sun R; Tian Z
Cell Transplant; 2011; 20(11-12):1731-46. PubMed ID: 21669033
[TBL] [Abstract][Full Text] [Related]
2. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
Jiang W; Zhang C; Tian Z; Zhang J
Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
[TBL] [Abstract][Full Text] [Related]
3. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions.
Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q
Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431
[TBL] [Abstract][Full Text] [Related]
4. hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function.
Jiang W; Zhang C; Tian Z; Zhang J
Gene Ther; 2013 Nov; 20(11):1062-9. PubMed ID: 23759701
[TBL] [Abstract][Full Text] [Related]
5. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC
Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.
Gong JH; Maki G; Klingemann HG
Leukemia; 1994 Apr; 8(4):652-8. PubMed ID: 8152260
[TBL] [Abstract][Full Text] [Related]
7. Depletion of ascorbic acid impairs NK cell activity against ovarian cancer in a mouse model.
Kim JE; Cho HS; Yang HS; Jung DJ; Hong SW; Hung CF; Lee WJ; Kim D
Immunobiology; 2012 Sep; 217(9):873-81. PubMed ID: 22306178
[TBL] [Abstract][Full Text] [Related]
8. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
[TBL] [Abstract][Full Text] [Related]
9. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers.
Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T
Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075
[TBL] [Abstract][Full Text] [Related]
10. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
[TBL] [Abstract][Full Text] [Related]
12. Production of proinflammatory cytokines without invocation of cytotoxic effects by an Epstein-Barr virus-infected natural killer cell line established from a patient with hypersensitivity to mosquito bites.
Suzuki D; Tsuji K; Yamamoto T; Fujii K; Iwatsuki K
Exp Hematol; 2010 Oct; 38(10):933-44. PubMed ID: 20600581
[TBL] [Abstract][Full Text] [Related]
13. Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.
Barber A; Zhang T; DeMars LR; Conejo-Garcia J; Roby KF; Sentman CL
Cancer Res; 2007 May; 67(10):5003-8. PubMed ID: 17510432
[TBL] [Abstract][Full Text] [Related]
14. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
[TBL] [Abstract][Full Text] [Related]
15. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
[TBL] [Abstract][Full Text] [Related]
16. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
[TBL] [Abstract][Full Text] [Related]
17. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
18. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model.
Dou J; Wang Y; Wang J; Zhao F; Li Y; Cao M; Hu W; Hu K; He XF; Chu L; Jiang C; Gu N
Immunobiology; 2009; 214(6):483-92. PubMed ID: 19389515
[TBL] [Abstract][Full Text] [Related]
19. Augmenting therapy of ovarian cancer efficacy by secreting IL-21 human umbilical cord blood stem cells in nude mice.
Hu W; Wang J; Dou J; He X; Zhao F; Jiang C; Yu F; Hu K; Chu L; Li X; Gu N
Cell Transplant; 2011; 20(5):669-80. PubMed ID: 21054951
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression.
Rossi LE; Avila DE; Spallanzani RG; Ziblat A; Fuertes MB; Lapyckyj L; Croci DO; Rabinovich GA; Domaica CI; Zwirner NW
J Leukoc Biol; 2012 Feb; 91(2):321-31. PubMed ID: 22124136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
